New Clinical Guidance Issued for GLP-1 Use in Patients with Eating Disorders
An international panel of experts has established new recommendations for prescribing GLP-1 medications to patients with a history of or active eating disorders.
🧠Mind & Mental HealthPhoto: Medical Xpress
Key points
- Clinicians are advised to screen for eating disorders before prescribing GLP-1 medications.
- Evidence-based therapy should accompany medication for patients with a history of disordered eating.
- Active eating disorders, such as anorexia or bulimia, are cited as reasons to avoid or exercise extreme caution with these drugs.
A new study published in World Psychiatry provides clinical guidance on the use of GLP-1 receptor agonists for patients with eating disorders. While these medications are effective for managing type 2 diabetes and weight, their impact on appetite and satiety can pose risks for individuals with disordered eating patterns. A panel of 45 experts, including researchers and individuals with lived experience, developed these recommendations to help clinicians navigate treatment decisions safely.
The consensus guidelines emphasize the importance of screening patients for current or past eating disorders before initiating GLP-1 therapy. The panel advises that these medications should generally be avoided for individuals with active conditions such as anorexia nervosa, atypical anorexia nervosa, or bulimia nervosa, particularly when significant food restriction or weight loss is present. For those who do receive treatment, the authors recommend consistent monitoring and the integration of evidence-based therapy.
What to know: The guidance is not a universal rule but a framework for personalized care. Clinicians are encouraged to evaluate each patient's specific nutritional needs, health history, and treatment goals. Always consult with a healthcare provider to discuss whether a specific medication is appropriate for your individual medical situation.
Source Medical Xpress — medicalxpress.com/news/2026-11-guidance-glp-medication-disorders.html ↗
Read next
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…
🏃FitnessA Structured Approach to Beginning a Strength and Cardio Routine
A new four-week training program offers beginners a guided path to incorporating strength training and cardiovascular exercise into their daily lives.
🏥Public HealthRecall Issued for Generic Propranolol Over Potential Metal Contamination
Breckenridge Pharmaceutical has initiated a voluntary recall of one lot of generic propranolol capsules due to the potential presence of metal fragments.
🥗NutritionUnderstanding Food Science: Why Some Leftovers Freeze Better Than Others
Freezing leftovers is an effective way to minimize food waste, though the success of the process depends on the cellular structure and composition of the food being store…